Today, BioPorto A/S has received a request to convene an extraordinary General Meeting from a group of shareholders under article 5 c of the company articles. The purpose of the meeting is election of board members. The company will convene an extraordinary General Meeting within 14 days, as specified in article 5 c.
Further information:
Thea Olesen, CEO
Christina Thomsen, Investor Relations
Tel. +45 45 29 00 00, e-mail investor@bioporto.com
